Physician profile
Haiyan Wang
NPI 1124639034
$1,287.22
in general payments reported to CMS, 2019-2025
12 companies · $407 in 2025
The $407 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $374 · 2023: $214 · 2024: $292 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $912.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $344.15 | 2023-2025 | |
| Lundbeck LLC | $241.22 | 2022-2025 | Vyepti |
| Novartis Pharmaceuticals Corporation | $126.65 | 2024 | |
| Ucb, INC. | $120.00 | 2025 | Nayzilam |
| Harmony Biosciences LLC | $116.93 | 2022 | |
| Impel Pharmaceuticals INC. | $114.92 | 2022 | |
| Pfizer INC. | $89.30 | 2024-2025 | |
| Emd Serono, INC. | $41.25 | 2023 | Mavenclad |
| Neurelis, INC. | $30.15 | 2025 | Valtoco |
| Boston Scientific Corporation | $24.81 | 2024 | |
| Mml US, INC. | $23.54 | 2025 | Reactiv8 |
| Lilly USA, LLC | $14.30 | 2023 | Emgality |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Haiyan Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.